Parker Waichman LLP

Stanford Next to Limit Drug Maker Financing of Education

Over growing concern about the influence drug makers have on medical education, Stanford University is expected to announce it will severely restrict industry financing of doctors’ continuing education at its medical school.  Drug makers have long been funding those annual refresher courses that most doctors nationwide must take and while industry claims its money is […]

Over growing concern about the influence <"https://www.yourlawyer.com/practice_areas/defective_drugs">drug makers have on medical education, Stanford University is expected to announce it will severely restrict industry financing of doctors’ continuing education at its medical school.  Drug makers have long been funding those annual refresher courses that most doctors nationwide must take and while industry claims its money is intended for the benefit of education, critics argue that industry only pays for classes that promote their products.

Following the announcement, Stanford will no longer allow drug and device companies to specify which courses they wish to finance.  Rather, drug and device makers will be asked to contribute only to a school-wide pool of money for use to fund any class, including those never mentioning a company’s products.  According to the Prescription Project, in doing so, Stanford will become the sixth major medical school joining those at the universities of Massachusetts, Pittsburgh, Colorado, Kansas, and California Davis to create such a school-wide pool; the Memorial Sloan-Kettering Cancer Center banned all industry support for its doctor classes.  Prescription Project is a nonprofit organization that is generally in opposition to industry financing of medical education.  

Dr. David Korn, chief scientific officer of the Association of American Medical Colleges, said Stanford’s new policy was “an extremely important step forward”; the association recently recommended medical schools contribution pooling to protect teachers from commercial influences.  Ken Johnson, a spokesman for the Pharmaceutical Research and Manufacturers of America, said “America’s pharmaceutical research companies have taken positive steps to help ensure they provide nothing but accurate and balanced information to health care providers.”  Meanwhile, Dr. Philip A. Pizzo, dean of Stanford’s School of Medicine, said that Stanford wanted to take a firm stand, even if it meant losing drug and device company funding for education.  “I want to make sure we’re not marketing for industry or being influenced by their marketing,” Pizzo said.

Dr. Murray Kopelow, chief executive of the Accreditation Council for Continuing Medical Education, said that Stanford’s new policy was part of a growing push in medical education to further separate crucial medical information from marketing messages.  “It’s a good plan, and it’s a big deal that a place like Stanford has adopted it,” Dr. Kopelow said. “When this is all over, medical education will not be the same as what it’s been.”

Last April 2007, Senator Charles E. Grassley, Republican-Iowa, issued a report documenting how drug makers used classes to increase product sales.  In a recent statement, Grassley said, “Reforms based on transparency can foster accountability and build confidence in medical education and, in turn, the practice of medicine.”  Since Grassley initiated his investigation, more and more drug makers have been publicizing their lists of educational grant recipients.  Also, Pfizer just announced it would no longer directly support commercial medical education companies.

Educational classes have long been offered to doctors at no charge and often included a free meal.  Many believe that to ensure no bias or conflict of interests, future classes might require doctors to pay for the classes they take, something some doctors have said they would oppose.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
They did their job. Thank you great professional highly recommend them
Donald Brown
4 years ago
5 Star Reviews 150
Parker Waichman are the best. They are always there for you. Theh really care about you. Thank you Jorge peniche and Linda Ingber for helping me
Ramon Mella
4 years ago
5 Star Reviews 150
Working with Nicole Copertino made them process so easy, As a retire Police officer and veteran she very professional and at the same time made me feel human not just broke client or a “PAY DAY” for her. Keep up the excellent work
Jerry Joly
10 months ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201